These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28503689)

  • 21. p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.
    Guo J; Xie N; Li G; Zhang Y; Lv F; Guo S; Feng Y; Cao CM; Xiao RP
    J Mol Med (Berl); 2015 Oct; 93(10):1107-18. PubMed ID: 25894383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells.
    Seo HH; Kim SW; Lee CY; Lim KH; Lee J; Choi E; Lim S; Lee S; Hwang KC
    Biol Res; 2017 Jan; 50(1):1. PubMed ID: 28100269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
    Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
    Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways.
    Chen Y; Jiang J; Miao H; Chen X; Sun X; Li Y
    Int J Mol Med; 2013 Mar; 31(3):597-606. PubMed ID: 23340693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model.
    Jandt E; Mutschke O; Mahboobi S; Uecker A; Platz R; Berndt A; Böhmer FD; Figulla HR; Werner GS
    Vascul Pharmacol; 2010; 52(1-2):55-62. PubMed ID: 19951743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
    Huang C; Zhou M; Zheng X
    J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells.
    Wang F; Li C; Ding FH; Shen Y; Gao J; Liu ZH; Chen JW; Zhang RY; Shen WF; Wang XQ; Lu L
    Atherosclerosis; 2017 Dec; 267():10-18. PubMed ID: 29080545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroaustrasulfone alcohol inhibits PDGF-induced proliferation and migration of human aortic smooth muscle cells through inhibition of the cell cycle.
    Chen YC; Wen ZH; Lee YH; Chen CL; Hung HC; Chen CH; Chen WF; Tsai MC
    Mar Drugs; 2015 Apr; 13(4):2390-406. PubMed ID: 25898413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis.
    Moon CY; Ku CR; Cho YH; Lee EJ
    Biochem Biophys Res Commun; 2012 Jun; 423(1):116-21. PubMed ID: 22640742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
    J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
    Jing L; Wang W; Zhang S; Xie M; Tian D; Luo X; Wang D; Ning Q; Lü J; Wang W
    PLoS One; 2015; 10(3):e0118826. PubMed ID: 25760326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials.
    Cho HH; Han DW; Matsumura K; Tsutsumi S; Hyon SH
    Biomaterials; 2008 Mar; 29(7):884-93. PubMed ID: 18031806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation.
    Yan W; Li T; Yin T; Hou Z; Qu K; Wang N; Durkan C; Dong L; Qiu J; Gregersen H; Wang G
    Theranostics; 2020; 10(23):10712-10728. PubMed ID: 32929376
    [No Abstract]   [Full Text] [Related]  

  • 39. A potential strategy for in-stent restenosis: Inhibition of migration and proliferation of vascular smooth muscle cells by Cu ion.
    Zhang Y; Wang X; Ma Z; Bai B; Liu J; Yang L; Qin G; Zhang E
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111090. PubMed ID: 32600694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis.
    Scott S; O'Sullivan M; Hafizi S; Shapiro LM; Bennett MR
    Circ Res; 2002 Mar; 90(4):398-404. PubMed ID: 11884368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.